Nanotoxicology: Toxicity Evaluation of Nanomedicine Applications

The field of nanomedicine has risen quickly due to the increasing number of designer-made nanomaterials. These nanomaterials have the potential to manage diseases and change the way medicine is currently studied. However, the increased practice of using nanomaterials has shed light on how many concepts of nanomedicine and nanotoxicity have been overlooked. Nanotoxicology: Toxicity Evaluation of Nanomedicine Applications addresses the existing gaps between nanomedicine and nanotoxicity. This book also brings together up-to-date knowledge on advances toward safe-by-design nanomaterials and existing toxicity challenges. This book delivers a comprehensive coverage in the field with fundamental understanding, serving as a platform to convey essential concepts of nanotoxicology and how these concepts can be employed to develop advanced nanomaterials for a range of biomedical applications. This book is an effort to answer some of the thoughtful nanotoxicological complications and their auspicious probable solutions with new approaches and careful toxicity assessment. Key Features: Reveals novel nanoscale approaches, toxicity assessment, and biomedical applications Includes importance of nanotoxicity concepts in developing smart nanomaterials Highlights unique contributions and "A to Z" aspects on the state-of-the-art from global leaders Offers a complete package to learn fundamentals with recommendations on nanomaterials toxicity and safe-by-design nanomedicines Nanotoxicology: Toxicity Evaluation of Nanomedicine Applications illuminates the high potential of many innovative nanomaterials, ultimately demonstrating them to be promising substitutes for available therapies that can be effectively used in fighting a myriad of biomedical complications. Further, this book reports legal, ethical, safety, and regulatory issues associated with nanomaterials, which have often been neglected, if not overlooked in literature and limiting clinical translation at nanoscale level. It will equip readers with cutting-edge knowledge of promising developments in nanomedicine and nanotoxicology, along with potential future prospects. About the Author Hemant Kumar Daima is A/Professor at Amity University Rajasthan, India and honorary ‘Visiting Research Fellow’ at RMIT University, Melbourne, Australia. Prior to Amity University, he has worked as A/Professor of Nanomedicine at Siddaganga Institute of Technology, India; Research Associate/Tutor at RMIT University, Australia and Research Fellow at University of Rajasthan, India. Dr. Daima obtained his MSc (Biotechnology) from University of Rajasthan, India; PhD (Applied Biology and Nanobiotechnology) from RMIT University, Australia. Dr. Daima is founder of Nano-Bio Interfacial Research Laboratory (NBIRL), and in-charge of newly established Amity University Science and Instrumentation Center-II (AUSIC-II). S. L. Kothari, FBS, FISPM, FNASc, FNAAS is Distinguished Professor of Biotechnology and Vice-President of Amity Science Technology and Innovation Foundation (ASTIF) at Amity University Rajasthan, Jaipur, India. Professor S.L. Kothari graduated from University of Rajasthan, Jaipur, India in 1984 with PhD, and during his long career he held post-doctoral positions as Fulbright Fellow at the University of Illinois, Urbana-Champaign, USA (1983-84); University of Nottingham, UK as Commonwealth Academic Staff Fellow and Rockefeller Foundation Biotechnology Career Fellow (1989-1996); University of Tsukuba, Japan as Visiting Foreign Research Fellow (2003-04). He held academic positions as Professor, Head of Department and Dean Faculty of Science at the University of Rajasthan, Jaipur; and later as Director, Institute of Biotechnology and Pro Vice Chancellor of Amity University Rajasthan, Jaipur. His efforts resulted in to the establishment of Converging Technologies Centre (nano-bio-info-cogno) at the University of Rajasthan, Jaipur that imparts BTech-MTech dual